📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Pelican Therapeutics

1.1 - Company Overview

Pelican Therapeutics Logo

Pelican Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of next-generation TNF-based immunotherapy biologic agents, focused on developing and commercializing monoclonal antibody and fusion protein therapies designed to activate the immune system.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Pelican Therapeutics

Jounce Therapeutics Logo

Jounce Therapeutics

HQ: United States Website
  • Description: Provider of first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors, driven by a proprietary product engine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jounce Therapeutics company profile →
EOS Logo

EOS

HQ: Italy Website
  • Description: Provider of biopharmaceutical research and development focused on creating novel medicines for the treatment of cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EOS company profile →
Photocure Logo

Photocure

HQ: United States Website
  • Description: Provider of photodynamic specialty pharmaceuticals, including Hexvix/Cysview to improve bladder tumor detection and resection via Blue Light Cystoscopy, and Cevira, a photodynamic drug-device for non-surgical treatment of cervical HSIL; also supports patient registries and real-world evidence in bladder cancer. Norwegian-based.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Photocure company profile →
Crossbow Therapeutics Logo

Crossbow Therapeutics

HQ: United States Website
  • Description: Provider of next-generation immunotherapies, including T-Bolt therapies that precisely target cancer cell antigens, and CBX-250, a T-cell engager for myeloid leukemia demonstrating potency and specificity in preclinical models.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Crossbow Therapeutics company profile →
XinThera Logo

XinThera

HQ: United States Website
  • Description: Provider of drug discovery focused on building a small molecule oncology and immunology pipeline.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full XinThera company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Pelican Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Pelican Therapeutics

2.2 - Growth funds investing in similar companies to Pelican Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Pelican Therapeutics

4.2 - Public trading comparable groups for Pelican Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Pelican Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Pelican Therapeutics

What does Pelican Therapeutics do?

Pelican Therapeutics is a provider of next-generation TNF-based immunotherapy biologic agents, focused on developing and commercializing monoclonal antibody and fusion protein therapies designed to activate the immune system.

Who are Pelican Therapeutics's competitors?

Pelican Therapeutics's competitors and similar companies include Jounce Therapeutics, EOS, Photocure, Crossbow Therapeutics, and XinThera.

Where is Pelican Therapeutics headquartered?

Pelican Therapeutics is headquartered in United States.

How many employees does Pelican Therapeutics have?

Pelican Therapeutics has 1,000 employees 🔒.

When was Pelican Therapeutics founded?

Pelican Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Pelican Therapeutics in?

Pelican Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Pelican Therapeutics

Who are the top strategic acquirers in Pelican Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Pelican Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Pelican Therapeutics?

Top strategic M&A buyers groups and sectors for Pelican Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Pelican Therapeutics's sector and industry vertical

Which are the top PE firms investing in Pelican Therapeutics's sector and industry vertical?

Top PE firms investing in Pelican Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Pelican Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Pelican Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Pelican Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Pelican Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Pelican Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Pelican Therapeutics?

The key public trading comparables and valuation benchmarks for Pelican Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Pelican Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Pelican Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Pelican Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Pelican Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Pelican Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Pelican Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Pelican Therapeutics